Family Office Of America (FOFA) Liabilities and Shareholders Equity (2021 - 2026)

Family Office Of America (FOFA) reported Liabilities and Shareholders Equity of $2.3 million for Q1 2026, up 296.35% on a YoY basis from $570468.0 in Q1 2025, and up 46.53% sequentially from $1.5 million in Q4 2025.

Family Office Of America (FOFA) Liabilities and Shareholders Equity (2021 - 2026) Analysis & Trends

Family Office Of America (FOFA) has 6 years of Liabilities and Shareholders Equity data on file, last reported at $2.3 million in Q1 2026.

  • For the quarter ending Q1 2026, Liabilities and Shareholders Equity rose 296.35% year-over-year to $2.3 million; the trailing twelve-month figure through Mar 2026 stood at $5.2 million (up 644.74% YoY), and the FY2025 full-year result was $1.5 million, up 7397.41% from the prior year.
  • Liabilities and Shareholders Equity grew to $2.3 million in Q1 2026, from $1.5 million in the prior quarter.
  • In the past five years, Liabilities and Shareholders Equity ranged from a high of $2.3 million in Q1 2026 to a low of $2431.0 in Q4 2023.
  • A 5-year average of $476445.1 and a median of $239812.0 in 2022 frame the typical range for Liabilities and Shareholders Equity.
  • Across the five-year window, Liabilities and Shareholders Equity plunged 99.18% in 2023 and surged 7397.41% in 2025, its largest moves.
  • Tracing FOFA's Liabilities and Shareholders Equity over 5 years: stood at $295461.0 in 2022, then sank by 99.18% to $2431.0 in 2023, then jumped by 746.61% to $20581.0 in 2024, then surged by 7397.41% to $1.5 million in 2025, then jumped by 46.53% to $2.3 million in 2026.
  • Business Quant data shows FOFA's Liabilities and Shareholders Equity at $2.3 million in Q1 2026, $1.5 million in Q4 2025, and $829347.0 in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Liabilities and Shareholders Equity (Qtr)
1 Abbott Laboratories 201.40 Bn 194.75 Bn 6.27 Bn 110.43 Bn
2 Stryker 122.29 Bn 119.41 Bn 3.81 Bn 46.29 Bn
3 Medtronic 105.01 Bn 96.40 Bn 6.41 Bn 93.03 Bn
4 Boston Scientific 64.81 Bn 63.59 Bn 3.61 Bn 44.35 Bn
5 Edwards Lifesciences 55.28 Bn 51.60 Bn 1.29 Bn 13.32 Bn
6 Dexcom 29.06 Bn 27.94 Bn 750.30 Mn 6.63 Bn
7 Koninklijke Philips 29.02 Bn 25.93 Bn 2.07 Bn 31.92 Bn
8 GE HealthCare Technologies 28.27 Bn 26.20 Bn 1.98 Bn 37.13 Bn
9 Smith & Nephew 25.80 Bn 25.22 Bn - 10.46 Bn
10 Family Office Of America 27.22 Mn 26.88 Mn 783,126.00 2.26 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 2.26 Mn
Dec 31, 2025 1.54 Mn
Sep 30, 2025 829,347.00
Jun 30, 2025 588,771.00
Mar 31, 2025 570,468.00
Dec 31, 2024 20,581.00
Sep 30, 2024 46,704.00
Jun 30, 2024 63,456.00
Mar 31, 2024 90,571.00
Dec 31, 2023 2,431.00
Sep 30, 2023 121,938.00
Jun 30, 2023 149,510.00
Mar 31, 2023 184,163.00
Dec 31, 2022 295,461.00
Sep 30, 2022 453,199.00
Jun 30, 2022 402,437.00
Dec 31, 2021 800,063.00